Header Logo

Connection

SAPNA PRADYUMAN PATEL to Alanine Transaminase

Back to Details
This is a "connection" page, showing publications SAPNA PRADYUMAN PATEL has written about Alanine Transaminase.
SAPNA PRADYUMAN PATEL
Connection Strength
0.042
Alanine Transaminase
  1. A Phase Ib/II Study of the BRAF Inhibitor Encorafenib Plus the MEK Inhibitor Binimetinib in Patients with BRAFV600E/K -mutant Solid Tumors. Clin Cancer Res. 2020 10 01; 26(19):5102-5112.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.